Published in Pharma Investments, Ventures and Law Weekly, May 15th, 2005
Atrium Biotechnologies' subordinate voting shares will trade on the Toronto Stock Exchange under the symbol "ATB.sv."
The 6,250,000 subordinate voting shares were sold to a syndicate of underwriters co-led by RBC Dominion Securities, Inc., and National Bank Financial, Inc., and including BMO Nesbitt Burns, Inc., CIBC World Markets, Inc., GMP Securities, Ltd.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly